Innovative Partnerships in Cardiac Care: Novartis, Cardea Health Inc., Heart HealthInstitute, and the Future of ASCVD Management in Ontario

The board of experts is comprised of three leading Cardiologists who are experts in their own sub-specialities within Cardiology.

Innovative Partnerships in Cardiac Care – Novartis, Cardea Health Inc. and HHI (1)Download

Data Points

Start Date: March 2023
Data period: 6 months
Number of Nurse Practitioners: 1 now moving to 2
Average ASCVD clinic days per month over the past 6 months: 2.5
Average ASCVD patients seen per day: 9
Highest number of ASCVD clinic days in a month: 5 days ( July 2023)
Patient Impact analysis: LDL decrease from baseline/initial value 2.5 down to 1.2 after 1 visit

Innovative Partnerships in Cardiac Care: Novartis, Cardea Health Inc., Heart HealthInstitute, and the Future of ASCVD Management in Ontario

The board of experts is comprised of three leading Cardiologists who are experts in their own sub-specialities within Cardiology.

Data Points

NAVIGATE

GET IN TOUCH

© 2023 Cardea Health Inc. Powered by Clearoute.